---
figid: PMC11019835__nihms-1973726-f0001
figtitle: Canonical and non-canonical function of CD55
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11019835
filename: nihms-1973726-f0001.jpg
figlink: /pmc/articles/PMC11019835/figure/F1/
number: F1
caption: (A) CD55 structure and its role in complement mediated pathway. (B) Non-complement
  role of CD55 signaling in cancer. CD55 can signal from outside in leading to activation
  of diverse oncogenic signaling pathways. Growth factors, cytokines, and prostaglandins
  augment or activate CD55 signaling. As a ligand for CD97, an epidermal growth factor
  seven-span transmembrane (EGF-7TM) receptor, CD55 can trigger intracellular signaling
  via Janus kinase/signal transducer and activator of transcription (JAK/STAT3) and
  GSK3β. These pathways can activate cascades that drive oncogenesis via Myc, resistance
  to chemotherapy via BRCA1 and MLH1, and CSC self-renewal via SOX2, OCT4, and NANOG.
papertitle: 'CD55 in cancer: Complementing functions in a non-canonical manner.'
reftext: Rashmi Bharti, et al. Cancer Lett. ;551:215935-215935.
year: '2024'
doi: 10.1016/j.canlet.2022.215935
journal_title: Cancer letters
journal_nlm_ta: Cancer Lett
publisher_name: ''
keywords: CD55 | DAF | Decay accelerating factor | Cancer stem cell | Complement pathway
automl_pathway: 0.9590983
figid_alias: PMC11019835__F1
figtype: Figure
redirect_from: /figures/PMC11019835__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11019835__nihms-1973726-f0001.html
  '@type': Dataset
  description: (A) CD55 structure and its role in complement mediated pathway. (B)
    Non-complement role of CD55 signaling in cancer. CD55 can signal from outside
    in leading to activation of diverse oncogenic signaling pathways. Growth factors,
    cytokines, and prostaglandins augment or activate CD55 signaling. As a ligand
    for CD97, an epidermal growth factor seven-span transmembrane (EGF-7TM) receptor,
    CD55 can trigger intracellular signaling via Janus kinase/signal transducer and
    activator of transcription (JAK/STAT3) and GSK3β. These pathways can activate
    cascades that drive oncogenesis via Myc, resistance to chemotherapy via BRCA1
    and MLH1, and CSC self-renewal via SOX2, OCT4, and NANOG.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MBL2
  - MBL3P
  - IL1A
  - IL1B
  - IL4
  - IL6
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - EGF
  - IFNA1
  - CD55
  - C1QA
  - C1QB
  - C1QC
  - C1R
  - C1S
  - C2
  - C3
  - IRF6
  - RBMS1
  - RBMS2
  - ADGRE5
  - ADGRE2
  - PITX1
  - MAPK8
  - MAPK9
  - MAPK10
  - LCK
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - AKT1
  - AKT2
  - AKT3
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - GSK3B
  - STAT3
  - CTNNB1
  - C5
  - C5AR1
  - C6
  - C9
  - C7
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - NANOG
  - BRCA1
  - SOX2
  - MLH1
  - MMP2
  - MYC
  - MMP9
  - LPS
  - Cancer
---
